Baseline characteristicsExBID (n/H11549123)ExQW (n/H11549129) Gender, n (%) Male 68 (55) 77 (60) Age at consent (yr) Mean/H11006SD 55/H1100610 56 /H1100611 Minimum, maximum 23, 79 23, 83 Race/ethnicity, n (%) Caucasian 68 (55) 81 (63)Black 9 (7) 6 (5)Asian 5 (4) 5 (4)Hispanic 41 (33) 37 (29) Mean/H11006 SDweight (kg) 94.3 /H1100618.9 97.0 /H1100620.7 Mean/H11006SDBMI (kg/m2) 33.0 /H110065.3 33.6 /H110065.5 Mean/H11006SDHbA1c (%) 8.4 /H110061.2 8.5 /H110061.1 HbA1c stratum, n 122 128 /H110219.0%, n (%) 88 (72) 90 (70) /H113509.0%, n (%) 34 (28) 38 (30) Mean/H11006SDFPG (mg/dl) 168 /H1100647 173 /H1100647 Mean/H11006SDduration of diabetes at screening (yr)a7/H1100657 /H110065 Diabetes management method at screening, n (%) Alone or in combination Metformin 87 (71) 103 (80)Sulfonylurea 34 (28) 40 (31)Thiazolidinedione 12 (10) 22 (17) Category Diet and Exercise 26 (21) 21 (16)Single oral antidiabetic therapy62 (50) 56 (43) Combination oral antidiabetic therapy35 (28) 52 (40)